This Stock Has Increased by 60% in a Month – Could This Be Just the Start?

Written by Emily J. Thompson, Senior Investment Analyst

LMND+13.13%

Source: Fool

Updated: Nov 17 2025

0mins

Source: Fool

Stock Performance: Lemonade (LMND) has been the top-performing stock in the portfolio, increasing by over 60% in the past month.
Earnings Discussion: The video will cover the company's latest earnings and potential factors that could enhance its business and stock value.

LMND

$96.57+Infinity%1D

Analyst Views on LMND

Wall Street analysts forecast LMND stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMND is 77.60 USD with a low forecast of 40.00 USD and a high forecast of 98.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Analyst Rating

2 Buy

3 Hold

1 Sell

Hold

Current: 85.360

Low

40.00

Averages

77.60

High

98.00

Current: 85.360

Low

40.00

Averages

77.60

High

98.00

Citizens

Outperform

maintain

$80 -> $85

2026-01-16

Reason

Citizens

Price Target

$80 -> $85

AI Analysis

2026-01-16

maintain

Outperform

Reason

Citizens raised the firm's price target on Lemonade to $85 from $80 and keeps an Outperform rating on the shares. Fourth quarter results are expected to reflect lighter catastrophe losses and limited mark-to-market impacts, with attention focused on pricing trends amid weakness in property lines, the analyst tells investors in a research note. While property pricing is declining, returns remain strong and casualty lines continue to see solid rate increases, pointing to a market in transition rather than broadly soft, the firm says.

Truist

Arvind Ramnani

Buy

initiated

$98

2026-01-06

Reason

Truist

Arvind Ramnani

Price Target

$98

2026-01-06

initiated

Buy

Reason

Truist analyst Arvind Ramnani initiated coverage of Lemonade with a Buy rating and $98 price target. Lemonade's digital-first approach to the insurance industry provides the company with significant structural advantages such as a lower overall cost base relative to traditional insurers, the analyst tells investors in a research note. Lemonade leverages AI, data, and digital tools across entire business, including customer service, claims, processing, and underwriting decisions, which helps to reduce costs and biases, Truist says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LMND

Unlock Now

Morgan Stanley

Underweight -> Equal Weight

upgrade

$53 -> $85

2025-12-16

Reason

Morgan Stanley

Price Target

$53 -> $85

2025-12-16

upgrade

Underweight -> Equal Weight

Reason

Morgan Stanley upgraded Lemonade to Equal Weight from Underweight with a price target of $85, up from $53. As the company continues to consistently deliver on outsized growth from autos, while seeing overall loss ratio improvements, Lemonade "presents a unique story" with total loss ratio stability and a clear path to EBITDA profitability by Q4 of 2026, the analyst tells investors.

Keefe Bruyette

Underperform

maintain

$35 -> $40

2025-11-25

Reason

Keefe Bruyette

Price Target

$35 -> $40

2025-11-25

maintain

Underperform

Reason

Keefe Bruyette raised the firm's price target on Lemonade to $40 from $35 and keeps an Underperform rating on the shares. The firm sees modest downside to consensus estimates in 2026, the analyst tells investors in a research note.

About LMND

Lemonade, Inc. offers renters, homeowners, car, pet, and life insurance. The Company operates through the United States, Europe, including the United Kingdom, providing insurance products to customers through various sales channels. The Company's digital substrate enables it to integrate marketing and onboarding with underwriting and claims processing, collecting, and deploying data. Its technology includes Data Advantage, AI Maya, AI Jim, CX.AI, Forensic Graph, Blender, and Cooper. AI Maya, its onboarding and customer experience bot, uses natural language to guide customers in joining the Company. AI Jim, its claims bot, takes the first notice of loss from its customer without human intervention. It offers pet insurance that covers diagnostics, procedures, medication, accidents or illness. Even its basic pet insurance offering covers blood tests, urinalysis, lab work, and computed tomography scans.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.